Q4 2023 Holdings
Filed 2024-02-14 | 23 holdings | $209.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amgen Inc(AMGN) | COM | 031162100 | $16.5M | 57,381 | 7.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $14.8M | 136,098 | 7.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $13.4M | 947,418 | 6.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $12.8M | 413,499 | 6.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $12.5M | 129,906 | 6.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $11.2M | 1,000,000 | 5.4% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $11.1M | 462,305 | 5.3% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $11.1M | 1,061,668 | 5.3% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $10.4M | 370,000 | 5.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $10.4M | 330,973 | 5.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $9.1M | 1,521,812 | 4.4% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $8.9M | 240,448 | 4.2% |
| Perrigo Co PLC(PRGO) | SHS | G97822103 | $8.4M | 260,000 | 4.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $7.6M | 265,000 | 3.6% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $7.2M | 140,000 | 3.4% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $6.7M | 107,500 | 3.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $6.7M | 307,721 | 3.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $6.5M | 108,000 | 3.1% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $5.5M | 677,350 | 2.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $5.2M | 230,000 | 2.5% |
| Prestige Consmr Healthcare I(PBH) | COM | 74112D101 | $5.2M | 85,000 | 2.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $4.2M | 103,324 | 2.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $3.7M | 192,667 | 1.8% |